MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter

References

1. 1.↵
   2. Varoquaux A,
   3. Rager O,
   4. Dulguerov P, et al

   . Diffusion-weighted and PET/MR imaging after radiation therapy for malignant head and neck tumors. Radiographics 2015;35:1502–27 doi:10.1148/rg.2015140029 pmid:26252192

   CrossRefPubMed
2. 2.↵
   2. de Bree R,
   3. van der Putten L,
   4. Brouwer J, et al

   . Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol 2009;45:386–93 doi:10.1016/j.oraloncology.2008.10.015 pmid:19095487

   CrossRefPubMedWeb of Science
3. 3.↵
   2. King AD,
   3. Thoeny HC

   . Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations. Cancer Imaging 2016;16:23 doi:10.1186/s40644-016-0080-6 pmid:27542718

   CrossRefPubMed
4. 4.↵
   2. Brouwer J,
   3. Bodar EJ,
   4. De Bree R, et al

   . Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement. Eur Arch Otorhinolaryngol 2004;261:417–22 pmid:14625779

   PubMed
5. 5.↵
   2. Tshering Vogel DW,
   3. Zbaeren P,
   4. Geretschlaeger A, et al

   . Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol 2013;23:562–69 doi:10.1007/s00330-012-2596-x pmid:22865270

   CrossRefPubMed
6. 6.↵
   2. Vandecaveye V,
   3. De Keyzer F,
   4. Nuyts S, et al

   . Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007;67:960–71 doi:10.1016/j.ijrobp.2006.09.020 pmid:17141979

   CrossRefPubMed
7. 7.↵
   2. Abdel Razek AA,
   3. Kandeel AY,
   4. Soliman N, et al

   . Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007;28:1146–52 doi:10.3174/ajnr.A0491 pmid:17569975

   Abstract/FREE Full Text
8. 8.↵
   2. Hwang I,
   3. Choi SH,
   4. Kim YJ, et al

   . Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging. AJNR Am J Neuroradiol 2013;34:2343–48 doi:10.3174/ajnr.A3603 pmid:23811978

   Abstract/FREE Full Text
9. 9.↵
   2. King AD,
   3. Mo FK,
   4. Yu KH, et al

   . Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20:2213–20 doi:10.1007/s00330-010-1769-8 pmid:20309553

   CrossRefPubMed
10. 10.↵
    2. Mukherji SK,
    3. Wolf GT

    . Evaluation of head and neck squamous cell carcinoma after treatment. AJNR Am J Neuroradiol 2003;24:1743–46 pmid:14561596

    FREE Full Text
11. 11.↵
    2. Vaid S,
    3. Chandorkar A,
    4. Atre A, et al

    . Differentiating recurrent tumours from post-treatment changes in head and neck cancers: does diffusion-weighted MRI solve the eternal dilemma? Clin Radiol 2017;72:74–83 doi:10.1016/j.crad.2016.09.019 pmid:27789026

    CrossRefPubMed
12. 12.↵
    2. Desouky SS,
    3. AboSeif SS,
    4. Shama SS, et al

    . Role of dynamic contrast enhanced and diffusion weighted MRI in the differentiation between post treatment changes and recurrent laryngeal cancers. Egypt J Radiol Nucl Med 2015;46:379–89 doi:10.1016/j.ejrnm.2015.01.012

    CrossRef
13. 13.↵
    2. Gouhar GK,
    3. El-Hariri MA

    . Feasibility of diffusion weighted MR imaging in differentiating recurrent laryngeal carcinoma from radionecrosis. Egypt J Radiol Nucl Med 2011;42:169–75 doi:10.1016/j.ejrnm.2011.05.010

    CrossRef
14. 14.↵
    2. King AD,
    3. Keung CK,
    4. Yu KH, et al

    . T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2013;34:1237–41 doi:10.3174/ajnr.A3378 pmid:23306012

    Abstract/FREE Full Text
15. 15.↵
    2. Becker M,
    3. Varoquaux AD,
    4. Combescure C, et al

    . Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences. Eur Radiol 2018;28:651–63 doi:10.1007/s00330-017-4999-1 pmid:28812148

    CrossRefPubMed
16. 16.↵
    2. Thoeny HC,
    3. De Keyzer F,
    4. King AD

    . Diffusion-weighted MR imaging in the head and neck. Radiology 2012;263:19–32 doi:10.1148/radiol.11101821 pmid:22438440

    CrossRefPubMed
17. 17.↵
    2. Varoquaux A,
    3. Rager O,
    4. Lovblad KO, et al

    . Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging 2013;40:842–52 doi:10.1007/s00259-013-2351-9 pmid:23436068

    CrossRefPubMed
18. 18.↵
    2. Perkins NJ,
    3. Schisterman EF

    . The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163:670–75 doi:10.1093/aje/kwj063 pmid:16410346

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Landis JR,
    3. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 doi:10.2307/2529310 pmid:843571

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Gu W,
    3. Pepe MS

    . Estimating the diagnostic likelihood ratio of a continuous marker. Biostatistics 2011;12:87–101 doi:10.1093/biostatistics/kxq045 pmid:20639522

    CrossRefPubMed
21. 21.↵
    R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2017
22. 22.↵
    2. Hein PA,
    3. Eskey CJ,
    4. Dunn JF, et al

    . Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004;25:201–09 pmid:14970018

    Abstract/FREE Full Text
23. 23.↵
    2. Farina D,
    3. Borghesi A,
    4. Botturi E, et al

    . Treatment monitoring of paranasal sinus tumors by magnetic resonance imaging. Cancer Imaging 2010;10:183–93 doi:10.1102/1470-7330.2010.0025 pmid:20713318

    CrossRefPubMed
24. 24.↵
    2. Šimundić AM

    . Measures of diagnostic accuracy: basic definitions. EJIFCC 2009;19:203–11 pmid:27683318

    PubMed
25. 25.↵
    2. McHugh ML

    . Interrater reliability: the kappa statistic. Biochem Med 2012;22:276–82 pmid:23092060

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Kuno H,
    3. Qureshi MM,
    4. Chapman MN, et al

    . CT texture analysis potentially predicts local failure in head and neck squamous cell carcinoma treated with chemoradiotherapy. AJNR Am J Neuroradiol 2017;38:2334–40 doi:10.3174/ajnr.A5407 pmid:29025727

    Abstract/FREE Full Text
27. 27.↵
    2. de Perrot T,
    3. Lenoir V,
    4. Domingo Ayllon M, et al

    . Apparent diffusion coefficient histograms of human papillomavirus-positive and human papillomavirus-negative head and neck squamous cell carcinoma: assessment of tumor heterogeneity and comparison with histopathology. AJNR Am J Neuroradiol 2017;38:2153–60 doi:10.3174/ajnr.A5370 pmid:28912282

    Abstract/FREE Full Text
28. 28.
    2. Brierley JD,
    3. Gospodarowicz MK,
    4. Wittekind C

    . TNM Classification of Malignant Tumours. 8th ed. Oxford: Wiley-Blackwell; 2017